EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comparing the distribution of Hodgkin lymphoma subtypes and survival outcomes between Latin American and US patients

Bryan Valcarcel, Ana Milena Cantillo Garcia, Sofía Gabriela Rivarola, German R. Stemmelin, Maria Elvira Enciso Arrua, Alana von Glasenapp, Alfredo R. Quiroz, Fernando Warley, Maria Orlova, Jule F. Vasquez, Denisse Castro, Brady Beltran und 5 weitere

Blood Global Hematology · 2025

DOI: 10.1016/j.bglo.2025.100002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Global Hematology, 2025. Verfasst von Bryan Valcarcel und 16 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Society of Hematology.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The lack of lymphoma registries in Latin America limits our understanding of epidemiology and outcomes compared with other countries. We compared the distribution of classical Hodgkin lymphoma (HL) subtypes and overall survival (OS) in Latin American patients with those in the United States. We conducted a retrospective cohort study among newly diagnosed adults (aged ≥16 years) during 2010 to 2020. Hospital-based data for Latin American patients (n = 818) were compared with data from a US population–based registry (n = 18 615). Survival analyses were restricted to patients who received therapy, and a propensity match was performed between Latin American and US patients, considering race and ethnicity. Latin American patients had the highest percentage of mixed cellularity HL (26% vs 13%-19% in other US race and ethnicity subgroups; P < .001). Mixed cellularity was significantly higher in Peru (47%) and Cuba (46%). With a median follow-up of 63 months in the matched cohort, the 5-year OS was comparable between Latin American and all US patients (87% vs 87%; P = .960). Outcomes were consistent in subgroup analyses, except for lower OS among Latin American patients aged 15 to 39 years (92% vs 95%; P = .030). Latin American patients likely exhibit a distinct distribution of HL subtypes, and outcomes were generally comparable to those of US patients, although findings need validation. Our findings suggest an opportunity to investigate further etiologic factors for HL development and the differential impact of health care and social determinants of health factors on survivorship outcomes to improve the survival of patients with HL globally.

Förderung

  • American Society of Hematology

Zitieren

APA

Valcarcel, B., Garcia, A. M. C., Rivarola, S. G., Stemmelin, G. R., Arrua, M. E. E., Glasenapp, A. V., Quiroz, A. R., Warley, F., Orlova, M., Vasquez, J. F., Castro, D., Beltran, B., Torres, M. A., Irigoin, V., Oliver, C., Rios-Jiménez, R. O., & Malpica, L. (2025). Comparing the distribution of Hodgkin lymphoma subtypes and survival outcomes between Latin American and US patients. Blood Global Hematology. https://doi.org/10.1016/j.bglo.2025.100002

Vancouver

Valcarcel B, Garcia AMC, Rivarola SG, Stemmelin GR, Arrua MEE, Glasenapp AV, et al. Comparing the distribution of Hodgkin lymphoma subtypes and survival outcomes between Latin American and US patients. Blood Global Hematology. 2025. doi:10.1016/j.bglo.2025.100002

BibTeX
@article{Valcarcel2025,
  author = {Valcarcel, Bryan and Garcia, Ana Milena Cantillo and Rivarola, Sofía Gabriela and Stemmelin, German R. and Arrua, Maria Elvira Enciso and Glasenapp, Alana von and Quiroz, Alfredo R. and Warley, Fernando and Orlova, Maria and Vasquez, Jule F. and Castro, Denisse and Beltran, Brady and Torres, Maria A. and Irigoin, Victoria and Oliver, Carolina and Rios-Jiménez, Rosa O. and Malpica, Luis},
  title = {Comparing the distribution of Hodgkin lymphoma subtypes and survival outcomes between Latin American and US patients},
  journal = {Blood Global Hematology},
  year = {2025},
  doi = {10.1016/j.bglo.2025.100002}
}
Kostenlos starten →